New NIH security rules for genomic data sets are slowing research, prompting workarounds
By Georgia Michelman,
Science
| 06. 18. 2026
In the spring of 2025, Andrew Lynn, a developmental cognitive neuroscientist at the University of Louisville (UofL), was starting a research project that would rely on data from the Adolescent Brain Cognitive Development (ABCD) Study, a U.S. effort to explore what affects children’s health and brain growth. But when he navigated to its website to download the data, he came across a worrisome announcement invoking an unfamiliar acronym: NIST SP 800-171.
He learned the acronym referred to a National Institute of Standards and Technology (NIST) protocol for handling highly sensitive data, which now covered genomic information from ABCD’s participants. Lynn actually planned to analyze only nongenomic data, such as MRI scans and questionnaires. But the ABCD site said scientists wanting access to any of its data would soon need compliant computer servers, which he and his UofL colleagues did not have.
Unable to meet the deadline, his group lost access to ABCD’s data for 2 months before finding a limited and temporary workaround. His research output has slowed—concerning for a junior faculty member working toward tenure. “I take data...
Related Articles
By Emma McDonald Kennedy
| 10.29.2026
At the beginning of Nathan Fielder and Lance Oppenheim’s blockbuster documentary You Can See Everything, Billy Evans (partner of Theranos founder and convicted fraudster Elizabeth Holmes), says that they decided to do the film for one purpose: “radical transparency.” As they work on “Theranos 2.0,” Evans and Holmes want to show the public that she has been misunderstood –– painted as a liar and a fraud in the public imagination (and the courts) despite, as she claims in the...
By Jonquilyn Hill, Vox | 10.18.2026
By Roxanne Khamsi, The Atlantic | 10.16.2026
In recent months, news came out about several distressing cases that have underscored the risks of gene therapy, which delivers DNA to a patient’s cells to treat disease. All of these cases have one thing in common that’s not apparent...
By Rebecca Roberts, The Scientist | 10.11.2026
Heritable genome editing in human embryos is once again under intense scrutiny after the publication of an opinion piece in Trends in Genetics at the end of last month.1 In the paper, Cathy Tie, the founder and chief...